Professor, Pediatrics, University of Cincinnati College of Medicine
Pulmonology
Dr. Bruce C. Trapnell, MD
|
|
Give Review
Dr. Bruce C. Trapnell works in the field of Pulmonology. He researched medicine at University of Maryland School of Medicine. University of Maryland School of Medicine has a rank of 37 in research and a 52 in primary care Bruce C. Trapnell is a published doctor. He published 43 publications, including: 'Epidermal growth factor receptor signaling regulates granulocyte-macrophage colony-stimulating factor production by airway epithelial cells and established allergic ai...' Dr. Bruce C. Trapnell is registered with Medicare and accepts Medicare payments.
Publications
- Epidermal growth factor receptor signaling regulates granulocyte-macrophage colony-stimulating factor production by airway epithelial cells and established allergic ai...
- Pulmonary macrophage transplantation therapy.
- Early changes in clinical, functional, and laboratory biomarkers in workers at risk of indium Lung disease.
- The dawn of protein-folding therapeutics.
- Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune Pulmonary alveolar proteinosis.
- Use of Induced Pluripotent Stem Cells To Recapitulate Pulmonary Alveolar Proteinosis Pathogenesis.
- Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphang...
- Cell Therapy for Lung Diseases: Report from an NIH-NHLBI Workshop November 13-14, 2012.
- Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.
- Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduce...
- Indium Lung Disease.
- Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to Cystic fibrosis.
- Phase 2 Clinical Trial of a Recombinant Adeno-associated Virus Vector Expressing Alpha 1 Antitrypsin: Interim Results.
- Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease.
- Keratinocyte Growth Factor Augments Pulmonary Innate Immunity through Epithelium-driven, GM-CSF-dependent Paracrine Activation of Alveolar Macrophages.
- Relationship Among Diffuse Pulmonary Fibrosis, Alveolar Proteinosis And Anti-GM-CSF Autoantibodies.
- Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.
- Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis.
- Hereditary Pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.
- Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other Diseases.
- Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce Pulmonary alveolar proteinosis in nonhuman primates.
- Inhaled granulocyte/macrophage-colony stimulating factor as therapy for Pulmonary alveolar proteinosis.
- The molecular basis of Pulmonary alveolar proteinosis.
- Human GM-CSF autoantibodies and reproduction of Pulmonary alveolar proteinosis.
- A novel biomarker-guided immunomodulatory approach for the therapy of sepsis.
- Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.
- Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.
- Quantitative analysis of longitudinal response to aerosolized granulocyte-macrophage colony-stimulating factor in two adolescents with autoimmune Pulmonary alveolar pr...
- Familial Pulmonary alveolar proteinosis caused by mutations in CSF2RA.
- Granulocyte/macrophage colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy individuals.
- alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note.
- Molecular pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease: a meeting review.
- PU.1 redirects adenovirus to lysosomes in alveolar macrophages, uncoupling internalization from infection.
- GM-CSF autoantibodies and neutrophil dysfunction in Pulmonary alveolar proteinosis.
- GM-CSF regulates a PU.1-dependent transcriptional program determining the Pulmonary response to LPS.
- Disruption of granulocyte macrophage-colony stimulating factor production in the Lungs severely affects the ability of mice to control Mycobacterium tuberculosis infec...
- High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic Pulmonary alveol...
- PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor.
- GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma R-mediated phagocytosis and the IL-18/IFN-gamma -mediated molecular connection between innate and adaptive immu...
- Endocytic internalization of adenovirus, nonspecific phagocytosis, and cytoskeletal organization are coordinately regulated in alveolar macrophages by GM-CSF and PU.1.
- Granulocyte macrophage-colony stimulating factor augmentation therapy in sepsis: is there a role?
- Gm-CSF regulates Pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense.
Schools
University Of Maryland School Of Medicine
Ohio St University Hosps
Nih Bethesda
Conditions Treated
- Asthma
- Bird Flu
- Bronchiectasis
- Bronchitis
- View All
Doctors Specialties
- Pulmonology
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
Ohio State University Hospital -
University of Maryland School of Medicine
Hospital
-
Cincinnati Children's Hospital Medical Center -
University of Cincinnati Medical Center
Drug Facts
| NPI NUMBER | 1134177314 | |
| NPPES Provider LastName | TRAPNELL | |
| NPPES Provider FirstName | BRUCE | |
| NPPES Provider ZIPCode | 452194231 | |
| NPPES Provider State | OH | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 380.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134177314 |
| Last Name Of The Provider | TRAPNELL |
| First Name Of The Provider | BRUCE |
| View All |
Similar Doctors
|
|
Dr. Ann M. Romaker, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohammad A. Sheatt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Halvonik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ralph J. Panos, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|